The interaction with FABP3 involves the C-terminal region of αSyn, and a synthetic peptide corresponding to this region is capable of disrupting the αSyn–FABP3 complex; thus, it was suggested that administration of this peptide might be useful in preventing the progression of PD (45). The gene discussed is FABP3; the disease is Parkinson disease.